The genetics of the amyloidoses

Joel N. Buxbaum, Clement E. Tagoe

Research output: Contribution to journalArticle

123 Citations (Scopus)

Abstract

The amyloidoses are diseases in which abnormalities in the secondary structure of precursor proteins result in decreased solubility under physiologic conditions, with subsequent organ compromise. A total of 18 proteins have been definitively identified as amyloid precursors associated with human disease. Mutations in the genes that encode some of these proteins produce autosomal dominant disease in mid to late adult life. Until recently, the late onset has obscured the familial nature of some of the disorders. This is especially true in the apparently sporadic disease-producing deposits found even later in life. In many instances, these deposits are derived from precursors encoded by wild-type genes (perhaps influenced by alleles that are polymorphic in the normal population); in other cases, they represent autosomal dominant disease with age-dependent penetrance. The genetic aspects of amyloid diseases produced by the deposition of four different proteins have been investigated in detail and provide insights into the particular diseases and amyloidogenesis in general.

Original languageEnglish (US)
Pages (from-to)543-569
Number of pages27
JournalAnnual Review of Medicine
Volume51
DOIs
StatePublished - 2000
Externally publishedYes

Fingerprint

Amyloidosis
Amyloid
Deposits
Genes
Secondary Protein Structure
Proteins
Protein Precursors
Penetrance
Genetics
Solubility
Alleles
Mutation
Population

Keywords

  • Alzheimer's disease
  • Amyloidosis
  • Familial Mediterranean fever
  • Serum amyloid A
  • Transthyretin

ASJC Scopus subject areas

  • Cell Biology
  • Medicine(all)

Cite this

The genetics of the amyloidoses. / Buxbaum, Joel N.; Tagoe, Clement E.

In: Annual Review of Medicine, Vol. 51, 2000, p. 543-569.

Research output: Contribution to journalArticle

Buxbaum, Joel N. ; Tagoe, Clement E. / The genetics of the amyloidoses. In: Annual Review of Medicine. 2000 ; Vol. 51. pp. 543-569.
@article{ca69ea28a6414acb9cb55e3cb4900bcd,
title = "The genetics of the amyloidoses",
abstract = "The amyloidoses are diseases in which abnormalities in the secondary structure of precursor proteins result in decreased solubility under physiologic conditions, with subsequent organ compromise. A total of 18 proteins have been definitively identified as amyloid precursors associated with human disease. Mutations in the genes that encode some of these proteins produce autosomal dominant disease in mid to late adult life. Until recently, the late onset has obscured the familial nature of some of the disorders. This is especially true in the apparently sporadic disease-producing deposits found even later in life. In many instances, these deposits are derived from precursors encoded by wild-type genes (perhaps influenced by alleles that are polymorphic in the normal population); in other cases, they represent autosomal dominant disease with age-dependent penetrance. The genetic aspects of amyloid diseases produced by the deposition of four different proteins have been investigated in detail and provide insights into the particular diseases and amyloidogenesis in general.",
keywords = "Alzheimer's disease, Amyloidosis, Familial Mediterranean fever, Serum amyloid A, Transthyretin",
author = "Buxbaum, {Joel N.} and Tagoe, {Clement E.}",
year = "2000",
doi = "10.1146/annurev.med.51.1.543",
language = "English (US)",
volume = "51",
pages = "543--569",
journal = "Annual Review of Medicine",
issn = "0066-4219",
publisher = "Annual Reviews Inc.",

}

TY - JOUR

T1 - The genetics of the amyloidoses

AU - Buxbaum, Joel N.

AU - Tagoe, Clement E.

PY - 2000

Y1 - 2000

N2 - The amyloidoses are diseases in which abnormalities in the secondary structure of precursor proteins result in decreased solubility under physiologic conditions, with subsequent organ compromise. A total of 18 proteins have been definitively identified as amyloid precursors associated with human disease. Mutations in the genes that encode some of these proteins produce autosomal dominant disease in mid to late adult life. Until recently, the late onset has obscured the familial nature of some of the disorders. This is especially true in the apparently sporadic disease-producing deposits found even later in life. In many instances, these deposits are derived from precursors encoded by wild-type genes (perhaps influenced by alleles that are polymorphic in the normal population); in other cases, they represent autosomal dominant disease with age-dependent penetrance. The genetic aspects of amyloid diseases produced by the deposition of four different proteins have been investigated in detail and provide insights into the particular diseases and amyloidogenesis in general.

AB - The amyloidoses are diseases in which abnormalities in the secondary structure of precursor proteins result in decreased solubility under physiologic conditions, with subsequent organ compromise. A total of 18 proteins have been definitively identified as amyloid precursors associated with human disease. Mutations in the genes that encode some of these proteins produce autosomal dominant disease in mid to late adult life. Until recently, the late onset has obscured the familial nature of some of the disorders. This is especially true in the apparently sporadic disease-producing deposits found even later in life. In many instances, these deposits are derived from precursors encoded by wild-type genes (perhaps influenced by alleles that are polymorphic in the normal population); in other cases, they represent autosomal dominant disease with age-dependent penetrance. The genetic aspects of amyloid diseases produced by the deposition of four different proteins have been investigated in detail and provide insights into the particular diseases and amyloidogenesis in general.

KW - Alzheimer's disease

KW - Amyloidosis

KW - Familial Mediterranean fever

KW - Serum amyloid A

KW - Transthyretin

UR - http://www.scopus.com/inward/record.url?scp=0034088778&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034088778&partnerID=8YFLogxK

U2 - 10.1146/annurev.med.51.1.543

DO - 10.1146/annurev.med.51.1.543

M3 - Article

VL - 51

SP - 543

EP - 569

JO - Annual Review of Medicine

JF - Annual Review of Medicine

SN - 0066-4219

ER -